- Indian pharma cos upbeat on biogenerics - Business Standard
- Simbiosys setting up 2 labs for high-end clinical tests - Financial Express
- New prospects at Hamdard University - Times of India
- Strong growth fuels ambition to expand at Neuland - OutSourcing-Pharma.com
- Ranbaxy Labs net sales at Rs 18884 mn, growth of 14% - Moneycontrol.com
Neuland Labs upbeat on high growth prospects - Business Standard
Neuland Labs upbeat on high growth prospectsBusiness Standard, IndiaThis year the focus will be on CRAMS both for drug discoveries and generic companies, clinical research and the new JV,” said Davuluri. The company is also looking at setting up its third manufacturing facility in India next year, a decision on the ...

